Elomotecan (BN-80927), a camptothecin analogue, is a potent inhibitor of topoisomerase I and II, is in phase I trials against advanced solid tumours by Ipsen and Roche pharmaceuticals. BN80927 shows high efficiency in vivo in tumor xenograft studies using human androgen-independent prostate tumors PC3 and DU145.

纯度：≥98%

CAS：220998-10-7